Lisocabtagene maraleucel (liso-cel) treatment of patients (pts) with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) and secondary CNS lymphoma: Initial results from TRANSCEND NHL 001 Meeting Abstract
| Authors: | Abramson, J. S.; Palomba, M. L.; Arnason, J. E.; Lunning, M. A.; Solomon, S. R.; Farazi, T.; Garcia, J.; Xie, B.; Newhall, K. J.; Dehner, C.; Siddiqi, T. |
| Abstract Title: | Lisocabtagene maraleucel (liso-cel) treatment of patients (pts) with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL) and secondary CNS lymphoma: Initial results from TRANSCEND NHL 001 |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 427s |
| Language: | English |
| ACCESSION: | WOS:000487345806277 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.15_suppl.7515 |
| Notes: | Meeting Abstract: 7515 -- Source: Wos |
